Virginia has received $67.4 million, the first payment in a Johnson and Johnson settlement requiring its subsidiary Janssen Pharmaceuticals to stop selling opioids in the U.S.; the Commonwealth will receive about $99.3 million total from the company over nine years.
“I’m thrilled that the money from these record-breaking settlements is on its way. My consumer protection section worked tirelessly to ensure that Virginians received the most funding possible and received it as quickly as possible. This helps the Commonwealth and individual localities fight back against the opioid epidemic and reduce, prevent, and treat addiction,” Attorney General Jason Miyares said in a press release.
Read More